Published in Dermatol Wochenschr on January 13, 1968
[Clinical and physiopathological findings in lichen sclerosus et atrophicus]. Arch Klin Exp Dermatol (1968) 0.81
[Systemic effects of ultraviolet, visible and infrared radiation in serial whole body irradiation. I. Oxygen utilization, flow properties of blood, hemodynamics, blood components and phagocytosis]. Dermatol Monatsschr (1989) 1.40
Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol (2002) 1.11
[Determination of the antinuclear factors in lupus erythematosus]. Dermatol Wochenschr (1965) 1.06
[On the behavior of glucose-6-phosphate dehydrogenase in the serum and erythrocytes of subjects with psoriasis]. Arch Klin Exp Dermatol (1967) 0.97
[Photochemotherapy of psoriasis using 8-methoxypsoralen and UVA. II. Binding of the photosensitizator to protein]. Dermatol Monatsschr (1976) 0.93
[Characteristics of psoriasis in childhood]. Dermatol Monatsschr (1979) 0.92
[Antinuclear factors in psoriasis vulgaris. (Preliminary report)]. Dermatol Wochenschr (1965) 0.91
[Pathogenesis and nosologic status of psoriatic arthropathy]. Hautarzt (1971) 0.89
[Immunologic and clinical studies on psoriasis]. Dtsch Gesundheitsw (1966) 0.89
Stable lipid peroxidation products in human skin: detection, ultraviolet light-induced increase, pathogenic importance. Experientia (1976) 0.88
[Photochemotherapy with 8-methoxypsoralen and UVA. III. Fluorescent microscopy studies of binding and transport of 8-MOP in the human skin]. Dermatol Monatsschr (1977) 0.87
High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol (1998) 0.86
Anti-endothelial antibodies in Takayasu arteritis. Arthritis Rheum (1994) 0.85
[Studies on the excretion of tryptophan metabolites in patients with circumscript and progressive scleroderma]. Dermatol Wochenschr (1968) 0.85
[Electron microscopy studies in lichen sclerosus and antrophicus]. Dermatol Monatsschr (1972) 0.85
Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients. Am J Clin Dermatol (2001) 0.85
[Abnormal HLA-DR antigen expression in monocytes of patients with systemic lupus erythematosus and psoriasis vulgaris]. Dermatol Monatsschr (1985) 0.84
[UV-A-1 therapy of subacute cutaneous lupus erythematosus]. Hautarzt (1993) 0.83
The influence of haematoporphyrin derivative and visible light on murine skin graft survival, epidermal Langerhans cells and stimulation of the allogeneic mixed leucocyte reaction. Scand J Immunol (1985) 0.83
Dermatomyositis: comparative studies of cutaneous photosensitivity in lupus erythematosus and normal subjects. Photodermatol Photoimmunol Photomed (2004) 0.83
[Thin-layer chromatographic deterimation of cholesterol and cholestrol esters in the serum of psoriasis vulgaris patients]. Dermatol Wochenschr (1968) 0.82
[The pathogenetic significance of "autoantibodies" in the NZB-W-F1 hybrids. II. Morphological studies]. Acta Biol Med Ger (1973) 0.82
[Lipid peroxidation of the human skin in vitro]. Dermatol Monatsschr (1971) 0.82
[Selected ultraviolet phototherapy (SUP) with fluorescent bulbs in psoriasis vulgaris. II. Effect on immune complexes, DNA antibodies and T cells in vivo]. Dermatol Monatsschr (1983) 0.82
[The lymphocyte transformation test in squamous epithelial carcinomas of the orofacial region]. Zahn Mund Kieferheilkd Zentralbl (1977) 0.82
[Clinical and physiopathological findings in lichen sclerosus et atrophicus]. Arch Klin Exp Dermatol (1968) 0.81
[Incorporation of 14C-linoleic acid in lipids of normal and psoriatic human skin (author's transl)]. Dermatol Monatsschr (1980) 0.81
[Studies on the pathogenesis of acrodermatitis enteropathica Danbolt-Closs]. Arch Klin Exp Dermatol (1967) 0.81
Effect of splenopentin (SP-5) on the antibody formation in immunosuppressed mice. Exp Clin Endocrinol (1986) 0.81
[Lymphocyte transformation test in bullous dermatoses]. Dermatol Monatsschr (1977) 0.81
Detection of interferon in the sera of patients with psoriasis, and its enhancement by PUVA treatment. Br J Dermatol (1983) 0.80
The influence of topical dermatological treatment modalities on epidermal Langerhans cells and contact sensitization in mice. Contact Dermatitis (1992) 0.80
[Clinical manifestations and diagnosis of penicillin allergy and other penicillin side effects]. Dermatol Monatsschr (1969) 0.80
[Immunological studies on the nosology of psoriasis arthropathica]. Allerg Asthma (Leipz) (1969) 0.80
Infrared-monitored cold response in the assessment of Raynaud's phenomenon. Clin Exp Dermatol (2006) 0.80
[On the evidence of antinuclear factors in various forms fof psoriasis]. Arch Klin Exp Dermatol (1966) 0.79
[Transitory acantholytic dermatosis (Grover) in an HIV infected patient]. Z Hautkr (1990) 0.79
[Acceleration of the ultra-violet provoked lipid peroxidation of human surface fat by means of anti-psoriatic substances]. Dermatol Monatsschr (1970) 0.79
Effective photodynamic therapy of actinic keratoses and Bowen's disease using microneedle perforation. Br J Dermatol (2013) 0.79
[Differentiation of the antipsoriatic and phototoxic effectiveness of topical PUVA therapy]. Hautarzt (1986) 0.79
[Epilepsy as an early symptom of lupus erythematosus]. Dermatol Wochenschr (1965) 0.79
[Stabilization of the erythrocyte membrane with UVA-irradiation using 8-methoxypsoralen]. Dermatol Monatsschr (1980) 0.79
[Promotion of hair growth with thiocyanate in guinea pigs]. Dermatol Monatsschr (1990) 0.79
[Inhibition of respiration in epidermal cells and fibroblasts by products of lipid peroxidation]. Dermatol Monatsschr (1971) 0.78
[Destruction of peripheral lymphocytes by 8-MOP and UVA]. Dermatol Monatsschr (1980) 0.78
[Liver involvement in erythropoietic protoporphyria]. Dermatol Monatsschr (1974) 0.78
Polyclonal B cell activation in the acute phase of systemic lupus erythematosus--aspects of pathogenic significance. J Invest Dermatol (1982) 0.78
[UV provoked lipid peroxidation in the human epidermis, corium and subcutis in vitro]. Acta Biol Med Ger (1972) 0.78
Determination of the horny layer profile by tape stripping in combination with optical spectroscopy in the visible range as a prerequisite to quantify percutaneous absorption. Skin Pharmacol Appl Skin Physiol (1999) 0.78
[Inactivation and protection of phosphofructokinase during 8-methoxypsoralen and UVA-treatment]. Dermatol Monatsschr (1980) 0.78
Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma). J Rheumatol (1995) 0.77
[On the problem of demonstration of antinuclear factors in scleroderma patients]. Dermatol Wochenschr (1966) 0.77
Comparison of the effects of calcipotriol, prednicarbate and clobetasol 17-propionate on normal skin assessed by ultrasound measurement of skin thickness. Skin Pharmacol (1994) 0.77
Hydroxyl radical scavenging and antipsoriatic activity of benzoic acid derivatives. Free Radic Biol Med (1990) 0.77
[Familial studies in lupus erythematosus]. Dermatol Wochenschr (1965) 0.77
[Recent studies on antinuclear factors with special reference to differential diagnostic and genetic viewpoints]. Z Gesamte Inn Med (1967) 0.77
[Dual diagnosis psychosis and substance use disorders in adolescents--part 1]. Fortschr Neurol Psychiatr (2010) 0.77
[Electron microscopy studies of the muscles in lupus erythematosus]. Dermatol Monatsschr (1973) 0.76
[Electron microscopy studies on the demonstration of virus-like particles in dermatomyositis]. Dermatol Monatsschr (1973) 0.76
Successful treatment of alopecia areata with efalizumab. J Eur Acad Dermatol Venereol (2008) 0.76
Studies on the effects of a high dose UVA-1 radiation therapy on surface markers and function of epidermal Langerhans cells. Arch Dermatol Res (1993) 0.76
Cis-urocanic acid as a mediator of ultraviolet-light-induced immunosuppression. Semin Hematol (1992) 0.76
PUVA therapy damages psoriatic and normal lymphoid cells within milliseconds. Arch Dermatol Res (1986) 0.76
The influence of interferon-gamma, interleukin-2, prostaglandin E2, and cyclosporine on the polyclonal and anti-DNA antibody secretion in lymphocyte cultures derived from patients with systemic lupus erythematosus. Arch Dermatol Res (1987) 0.76
[Differential diagnostic studies on lupus erythematosus chronicus discoides and lymphocyte infiltration Jessner-Kanof using the immunofluorescent technic]. Arch Klin Exp Dermatol (1968) 0.76
[The role of immunofluorescence methods in dermatology (technic and clinical use)]. Dermatol Monatsschr (1970) 0.76
[Electron microscopy examinations of the muscular tissue in psoriasis arthropathica]. Dermatol Monatsschr (1971) 0.76
Stimulation of the recruitment of epidermal Langerhans cells by splenopentin. Arch Dermatol Res (1990) 0.75
[Photochemotherapy by 8-methoxypsoralen and UVA in psoriasis vulgaris--clinical experiences in 5 dermatological departments of GDR (author's transl)]. Dermatol Monatsschr (1978) 0.75
[The effect of stored iron on experimental 2,4-dinitrochlorobenzene eczema in guinea pigs]. Arch Klin Exp Dermatol (1965) 0.75
Incorporation of 14C-linoleic acid in cerebrosides of psoriatic and normal human skin. Arch Dermatol Res (1981) 0.75
[Clinical and morphologic peculiarities in simultaneous occurrence of lupus erythematodes and exanthema from drugs]. Z Haut Geschlechtskr (1966) 0.75
[Comparative immunological studies in lupus erythematosus, primary chronic polyarthritis and psoriasis arthropathica]. Allerg Asthma (Leipz) (1969) 0.75
[Autoimmunology studies in psoriasis patients]. Dermatol Monatsschr (1969) 0.75
[On the diagnosis of dermatomyositis]. Dtsch Gesundheitsw (1966) 0.75
[Studies on the demonstration and the transferability of cellular antibodies in drug-induced exanthema]. Dermatol Wochenschr (1967) 0.75
[Recommendations for management and evaluation of epicutaneous, intracutaneous and prick tests and nasal and inhalative allergen test]. Z Erkr Atmungsorgane (1981) 0.75
[Measurement of skin temperature with the infra-red radiation measuring device by Kortum]. Dermatol Monatsschr (1969) 0.75
[The problems of autoimmunization as basis of the so-called collagenoses]. Z Gesamte Inn Med (1969) 0.75
[Immunologic studies of psoriasis patients with Brucella antigen]. Dermatol Wochenschr (1968) 0.75
[Therapy of lupus erythematosus during pregnancy]. Dtsch Gesundheitsw (1969) 0.75
[Studies with the loose body test and the antiglobulin consumption test in psoriasis patients]. Dermatol Wochenschr (1968) 0.75
[On the question of autoimmunization as the basis of the so-called collagenoses]. Z Gesamte Inn Med (1969) 0.75
[Basic principles of autoimmune diseases]. Dermatol Monatsschr (1969) 0.75
[On the therapy of recurrent verrucae vulgares]. Asthet Med (Berl) (1966) 0.75